Value
8.5/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 8.9 |
| P/S | 9.8 |
| EV/EBITDA | 8.1 |
| Fwd P/E | 9.7 |
| PEG | 6.8 |
- ▸Forward P/E: 7.4x
- ▸PEG: 1.06
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Global Indemnity is in a bullish technical breakout with excellent cash conversion and a durable dividend track record, but concentration in its non-admitted regulatory book and a quality score just below the engine's floor keep the setup below the bar for adding.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
89% of Global Indemnity's business sits on a non-admitted (surplus lines) regulatory basis, creating meaningful concentration risk tied to that specific regulatory structure. Bear case | The company should diversify its regulatory mix, reducing the non-admitted share below 80% of the business, over the next 12 months. | →Stable |
| CounterSurplus lines is the company's specialty niche and core competitive advantage in specialty insurance, so this concentration may be a deliberate strength rather than a diversifiable risk. | ||
Global Indemnity's quality score of 3.7 sits just below the 4.0 floor, even though the business shows excellent cash conversion with free cash flow at 1000% of net income. Quality breakdown | The overall quality score should rise above the 4.0 floor over the next 12 months as other quality components catch up to the strong cash conversion. | →Stable |
| CounterA 1000% FCF/NI ratio is unusually large and may reflect a one-time working-capital or reserve-release benefit rather than a durable trend, meaning quality could stay depressed. | ||
The stock is in a technical breakout — a golden cross with price above all major moving averages, RSI at 70, and bullish MACD. Chart pattern detection | The breakout should hold, with price staying above key moving averages over the next several months. | →Stable |
| CounterAn RSI already at 70 at the point of breakout leaves little room before the stock becomes overbought, raising the odds of a near-term pullback. | ||
Global Indemnity is a dividend aristocrat yielding 4.7%, though its earnings history shows a mixed beat/miss record (2 beats, 2 misses over the last 4 quarters). Catalyst breakdown | The dividend should be maintained or grown while the beat/miss ratio improves over the next 4 quarters. | →Stable |
| CounterA dividend aristocrat streak by itself doesn't guarantee future increases, and continued earnings volatility could pressure the payout if underwriting results deteriorate. | ||
The stock trades 37.2% below its analyst price target, offering a meaningful gap alongside conservative debt levels noted in the peer comparison. Estimated upside | The stock should close a meaningful portion of the 37.2% gap toward the analyst target over the next 12 months. | →Stable |
| CounterA wide gap to target combined with a below-floor quality score raises the risk that the target itself is stale or too optimistic for the current fundamentals. | ||
CounterSurplus lines is the company's specialty niche and core competitive advantage in specialty insurance, so this concentration may be a deliberate strength rather than a diversifiable risk.
CounterA 1000% FCF/NI ratio is unusually large and may reflect a one-time working-capital or reserve-release benefit rather than a durable trend, meaning quality could stay depressed.
CounterAn RSI already at 70 at the point of breakout leaves little room before the stock becomes overbought, raising the odds of a near-term pullback.
CounterA dividend aristocrat streak by itself doesn't guarantee future increases, and continued earnings volatility could pressure the payout if underwriting results deteriorate.
CounterA wide gap to target combined with a below-floor quality score raises the risk that the target itself is stale or too optimistic for the current fundamentals.
| Component | Sub-score |
|---|---|
| P/E | 8.9 |
| P/S | 9.8 |
| EV/EBITDA | 8.1 |
| Fwd P/E | 9.7 |
| PEG | 6.8 |
| Component | Sub-score |
|---|---|
| ROE | 1.6 |
| ROA | 1.1 |
| Gross margin | 0.0 |
| Op margin | 5.0 |
| Net margin | 3.8 |
| Current ratio | 1.2 |
| FCF quality | 10.0 |
| Moat | 5.8 |
| Piotroski F | 4.4 |
| Component | Sub-score |
|---|---|
| Rev growth | 3.8 |
| EPS growth | 3.4 |
| Component | Sub-score |
|---|---|
| RSI | 3.0 |
| MACD | 0.0 |
| OBV | 10.0 |
| MA position | 2.2 |
| Volume | 0.0 |
| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 10.0 |
| erm sentiment | 5.0 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.0 |
| Component | Sub-score |
|---|---|
| value rank | 6.7 |
| quality rank | 1.5 |
| growth rank | 3.4 |
| Component | Sub-score |
|---|---|
| bollinger | 7.7 |
| support resistance | 9.2 |
| 52w position | 6.0 |
| Component | Sub-score |
|---|---|
| short interest | 9.9 |
| days to cover | 9.7 |
| volatility | 0.0 |
| beta | 10.0 |
| debt equity | 10.0 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 3.3 |
| earnings timing | 5.0 |
| surprise avg | 5.6 |
| dividend safety | 7.5 |
Market cap $359M below $400M minimum. Not in investable universe.
L1:HARD_BLOCK:MARKET_CAPSetup— — No clear chart pattern; technical signals are mixed
EdgeInst Constrain — Small cap ($0.4B) below institutional reach
SuitabilitySpeculative — Binary industry: Insurance - Property & Casualty
The HOLD_IF_HOLDING verdict reflects the MOMENTUM gate's 3.0<4.5 outcome against Value at 8.5 and asymmetric R:R of 6.57.
The strongest dimensions are Value at 8.5, Risk (lower is worse) at 7.9, and Technical at 7.6; the weakest are Momentum at 3.0, Growth at 3.6, and Quality at 3.7. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 6.57 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifNon-admitted (surplus lines) business share falls below 75% of the total, from the current 89%.
Trip ifQuality score rises above 4.0 from the current 3.7.
Trip ifPrice closes below the 200-day moving average for more than 5 consecutive trading days.
Trip ifThe company cuts its dividend by more than 25%.
Trip ifThe gap to the analyst target compresses below 15%, from the current 37.2%.